èšåºæ®µéã®è£œè¬äŒç€Ÿã§ãã Plus Therapeutics, Inc. ã¯ãããããã®ä»ã®çŸæ£ã®æ£è
ã«å¯Ÿããæ²»çè¬ã®éçºã補é ãããã³åååã«éç¹ã眮ããŠããŸããå瀟ã®äž»ååè£è¬ã¯ãåçºæ§ç¥çµè èœè
«ã®æ£è
ã察象ãšããç¹èš±ååŸæžã¿ã®æŸå°ç·çæ³ã§ãã Rhenium NanoLiposomes ã§ãçŸåšãçšéèšå®èšåºè©Šéšããã§ãŒãº 1 ã«ãããŸããå瀟ã¯ãŸããåºåœ¢è
«çã®æ£è
ã察象ãšããç¹èš±ååŸæžã¿ã®ååŠçæ³ã§ãã DocePLUS ãšãåµå·£ããã®æ£è
ã察象ãšãããžã§ããªãã¯ååŠçæ³ã§ãã DoxoPLUS ãéçºäžã§ããå瀟㯠NanoTx, Corp. ãšã©ã€ã»ã³ã¹å¥çŽãçµã³ãNanoTx ã®ç¥çµè èœè
«æ²»çè¬ã®éçºãšåååãè¡ã£ãŠããŸããå瀟ã¯ä»¥å㯠Cytori Therapeutics, Inc. ãšããŠç¥ãããŠããŸãããã2019 幎 7 æã« Plus Therapeutics, Inc. ã«ç€Ÿåã倿ŽããŸãããPlus Therapeutics, Inc. 㯠1996 幎ã«èšç«ããããããµã¹å·ãªãŒã¹ãã£ã³ã«æ¬ç€Ÿã眮ããŠããŸãã